​

Vivos Therapeutics (VVOS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Vivos Therapeutics Revenue Highlights

Latest Revenue (Y)

$15.03M

Latest Revenue (Q)

$3.02M

Main Segment (Y)

Product

Vivos Therapeutics Revenue by Period

Vivos Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$15.03M8.91%
2023-12-31$13.80M-13.87%
2022-12-31$16.02M-5.10%
2021-12-31$16.89M29.23%
2020-12-31$13.07M14.68%
2019-12-31$11.39M200.43%
2018-12-31$3.79M-

Vivos Therapeutics generated $15.03M in revenue during NA 2024, up 8.91% compared to the previous quarter, and up 131.93% compared to the same period a year ago.

Vivos Therapeutics Revenue by Quarter

DateRevenueChange
2025-03-31$3.02M-18.44%
2024-12-31$3.70M-4.20%
2024-09-30$3.86M-4.79%
2024-06-30$4.05M18.57%
2024-03-31$3.42M5.26%
2023-12-31$3.25M-1.61%
2023-09-30$3.30M-2.77%
2023-06-30$3.40M-11.98%
2023-03-31$3.86M-2.35%
2022-12-31$3.95M-6.97%
2022-09-30$4.25M1.48%
2022-06-30$4.18M20.92%
2022-03-31$3.46M-21.26%
2021-12-31$4.39M-3.33%
2021-09-30$4.55M1.09%
2021-06-30$4.50M30.42%
2021-03-31$3.45M4.26%
2020-12-31$3.31M0.47%
2020-09-30$3.29M0.62%
2020-06-30$3.27M2.34%
2020-03-31$3.20M4.61%
2019-12-31$3.06M-7.84%
2019-09-30$3.32M32.06%
2019-06-30$2.51M-0.00%
2019-03-31$2.51M-

Vivos Therapeutics generated $3.02M in revenue during Q1 2025, up -18.44% compared to the previous quarter, and up 92.86% compared to the same period a year ago.

Vivos Therapeutics Revenue Breakdown

Vivos Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
VIP$2.48M----
Appliances$5.60M----
Billing Intelligence Services$840.00K----
Product$7.87M----
Service$7.16M----
Sponsorship Seminar Other$1.94M----
Center Revenue-$189.00K$561.00K$480.00K$341.96K
Management Service Revenue--$63.00K$313.00K-

Vivos Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (30.40%), Service (27.64%), Appliances (21.63%), VIP (9.60%), Sponsorship Seminar Other (7.49%), and Billing Intelligence Services (3.24%).

Quarterly Revenue by Product

Product/ServiceMar 25Dec 24Sep 24Jun 24Mar 24Dec 23Jun 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Product$1.81M$2.27M$1.96M$1.98M$1.67M----------
VIP$223.00K-$926.00K$1.17M$907.00K----------
Sponsorship Seminar Other$328.00K$1.30M$294.00K$224.00K$122.00K----------
Service$1.20M$1.43M$1.90M$2.08M$1.75M----------
Billing Intelligence Services$181.00K$196.00K$206.00K$213.00K$225.00K----------
Appliances$1.27M$1.30M$1.58M$1.58M$1.15M----------
Center Revenue-----$90.00K$25.00K$50.00K$105.00K$219.00K$186.00K$135.65K$134.49K$118.09K$91.77K
Management Service Revenue------$574.00K$-19.00K$11.00K$40.00K$24.00K$90.00K$90.00K$74.00K-

Vivos Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Product (36.11%), Appliances (25.35%), Service (23.96%), Sponsorship Seminar Other (6.53%), VIP (4.44%), and Billing Intelligence Services (3.60%).

Vivos Therapeutics Revenue Breakdown by Country

Quarterly Revenue by Country

CountryDec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Management Service Revenue$-19.00K$11.00K$40.00K$24.00K$90.00K$90.00K$74.00K-
Center Revenue$50.00K$105.00K$219.00K$186.00K$135.65K$134.49K$118.09K$91.77K

Vivos Therapeutics's latest quarterly revenue breakdown by geography, as of Dec 22: Center Revenue (161.29%), and Management Service Revenue (-61.29%).

Vivos Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RPIDRapid Micro Biosystems$28.05M$8.22M
HSCSHeart Test Laboratories$18.60M-
VVOSVivos Therapeutics$15.03M$3.02M
NUWENuwellis$8.74M$1.90M
NAOVNanoVibronix$2.28M$444.00K
TIVCTivic Health Systems$780.00K$70.00K
BBLGBone Biologics--
BJDXBluejay Diagnostics-$216.09K

VVOS Revenue FAQ

What is Vivos Therapeutics’s yearly revenue?

Vivos Therapeutics's yearly revenue for 2024 was $15.03M, representing an increase of 8.91% compared to 2023. The company's yearly revenue for 2023 was $13.8M, representing a decrease of -13.87% compared to 2022. VVOS's yearly revenue for 2022 was $16.02M, representing a decrease of -5.10% compared to 2021.

What is Vivos Therapeutics’s quarterly revenue?

Vivos Therapeutics's quarterly revenue for Q1 2025 was $3.02M, a -18.44% decrease from the previous quarter (Q4 2024), and a -11.79% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $3.7M, a -4.20% decrease from the previous quarter (Q3 2024), and a 13.85% increase year-over-year (Q4 2023). VVOS's quarterly revenue for Q3 2024 was $3.86M, a -4.79% decrease from the previous quarter (Q2 2024), and a 16.93% increase year-over-year (Q3 2023).

What is Vivos Therapeutics’s revenue growth rate?

Vivos Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -6.20%, and for the last 5 years (2020-2024) was 15.04%.

What are Vivos Therapeutics’s revenue streams?

Vivos Therapeutics's revenue streams in c 24 are VIP, Appliances, Billing Intelligence Services, Product, Service, and Sponsorship Seminar Other. VIP generated $2.48M in revenue, accounting 9.60% of the company's total revenue Appliances generated $5.6M in revenue, accounting 21.63% of the company's total revenue Billing Intelligence Services generated $840K in revenue, accounting 3.24% of the company's total revenue Product generated $7.87M in revenue, accounting 30.40% of the company's total revenue Service generated $7.16M in revenue, accounting 27.64% of the company's total revenue Sponsorship Seminar Other generated $1.94M in revenue, accounting 7.49% of the company's total revenue

What is Vivos Therapeutics’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Vivos Therapeutics was Product. This segment made a revenue of $7.87M, representing 30.40% of the company's total revenue.